The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population

被引:9
|
作者
Mao, Fei [1 ]
Niu, Xiao-Bing [1 ]
Gu, Shuo [1 ]
Ji, Lu [1 ]
Wei, Bing-Jian [1 ]
Wang, Heng-Bing [1 ]
机构
[1] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Urol, Huaian, Jiangsu, Peoples R China
关键词
Matrix metalloproteinase-7; Bladder cancer; Single nucleotide polymorphism; COLORECTAL-CANCER; POLYMORPHISMS; SUSCEPTIBILITY; CARCINOMA;
D O I
10.1007/s10238-019-00582-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The circulating matrix metalloproteinase-7 (MMP-7) levels are associated with the risk of bladder cancer (BC). MMP-7 gene -181A/G polymorphism may influence the expression of MMP-7 by affecting the transcriptional activity. A case-control study comprising 355 BC patients and 435 age- and gender-matched healthy controls was conducted in a Chinese Han population. The genotype of MMP-7 gene -181A/G polymorphism was determined by using polymerase chain reaction-restriction fragment length polymorphism method. Data revealed that MMP-7 gene -181A/G polymorphism increased the risk of BC under the homozygous and allelic models. However, no association between MMP-7 gene -181A/G polymorphism and BC risk was obtained after adjusting for age, gender, smoking habits and drinking habits. Subgroup analyses showed MMP-7 gene -181A/G polymorphism was associated with increased risk for BC among the smokers and drinkers. Furthermore, AG or GG genotype of -181A/G polymorphism was associated with larger tumor size and lymphatic metastasis in BC patients. To sum up, MMP-7 gene -181A/G polymorphism is not associated with the susceptibility to BC. However, subgroup analyses obtain significant association among the groups of smokers and drinkers. Larger studies in other ethnic groups are needed to ascertain the contribution of MMP-7 gene -181A/G polymorphism to BC risk.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 50 条
  • [1] The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population
    Fei Mao
    Xiao-Bing Niu
    Shuo Gu
    Lu Ji
    Bing-Jian Wei
    Heng-Bing Wang
    Clinical and Experimental Medicine, 2019, 19 : 565 - 570
  • [2] Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer
    Liao, Cheng-Hsi
    Chang, Wen-Shin
    Tsai, Chia-Wen
    Hu, Pei-Shin
    Wu, Hsi-Chin
    Hsu, Shih-Wei
    Chen, Guan-Liang
    Yueh, Te-Cheng
    Shen, Te-Chun
    Hsia, Te-Chun
    Bau, Da-Tian
    IN VIVO, 2018, 32 (05): : 1045 - 1050
  • [3] Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk
    Liao, Cheng-hsi
    Chang, Wen-shin
    Hsu, Wei-lin
    Hu, Pei-shin
    Wu, Hsi-chin
    Hsu, Shih-wei
    Wang, Bo-ren
    Yueh, Te-cheng
    Chen, Chao-hsuan
    Hsia, Te-chun
    Huang, Wen-chin
    Bau, Da-tian
    Tsai, Chia-wen
    ANTICANCER RESEARCH, 2023, 43 (01) : 381 - 387
  • [4] Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan
    Shih, Liang-Chun
    Li, Ching-Hao
    Sun, Kuo-Ting
    Chen, Liang-Yu
    Hsu, Che-Lun
    Hung, Yi-Wen
    Wu, Cheng-Nan
    Hsia, Te-Chun
    Shen, Te-Chun
    Chang, Wen-Shin
    Shih, Tzu-Ching
    Tsai, Chia-Wen
    Bau, Da-Tian
    ANTICANCER RESEARCH, 2018, 38 (04) : 2087 - 2092
  • [5] Association analysis between MDR1 genetic variant and breast cancer risk factors in Chinese Han population
    Hu, Yi
    Wang, Jingliang
    Tao, Haitao
    Wang, Huan
    Zhang, Xin
    Cheng, Yao
    Li, Ruixin
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [6] Association analysis between MDR1 genetic variant and breast cancer risk factors in Chinese Han population
    Yi Hu
    Jingliang Wang
    Haitao Tao
    Huan Wang
    Xin Zhang
    Yao Cheng
    Ruixin Li
    Medical Oncology, 2013, 30
  • [7] A Novel Nonsynonymous Variant of Matrix Metalloproteinase-7 Confers Risk of Liver Cirrhosis
    Hung, Tzu-Min
    Chang, Shin C.
    Yu, Wei-Hsuan
    Wang, Yu-Wen
    Huang, Cheng
    Lu, Shao-Chun
    Lee, Po-Huang
    Chang, Ming-Fu
    HEPATOLOGY, 2009, 50 (04) : 1184 - 1193
  • [8] Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer
    Szarvas, Tibor
    Becker, Markus
    vom Dorp, Frank
    Gethmann, Carolin
    Toetsch, Martin
    Bankfalvi, Agnes
    Schmid, Kurt W.
    Romics, Imre
    Ruebben, Herbert
    Erguen, Sueleyman
    CANCER SCIENCE, 2010, 101 (05) : 1300 - 1308
  • [9] Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
    El Demery, Mounira
    Demirdjian-Sarkissian, Gaiane
    Thezenas, Simon
    Jacot, William
    Laghzali, Yassine
    Darbouret, Bruno
    Culine, Stephane
    Rebillard, Xavier
    Lamy, Pierre-Jean
    CLINICAL AND TRANSLATIONAL MEDICINE, 2014, 3
  • [10] Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer
    Szarvas, Tibor
    Singer, Bernhard B.
    Becker, Markus
    Dorp, Frank Vom
    Jaeger, Tobias
    Szendroi, Attila
    Riesz, Peter
    Romics, Imre
    Ruebben, Herbert
    Erguen, Sueleyman
    BJU INTERNATIONAL, 2011, 107 (07) : 1069 - 1073